Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third‐ or Later‐Line Chemotherapy for CLDN18.2‐Positive and HER2‐Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol. - Maeda, Osamu; Tanaka, Chie; Furukawa, Kazuhiro; Miyata, Kazushi; Shimizu, Dai; Sugita, Shizuki; Nakanishi, Koki; Hirose, Takashi; Mizuno, Kazuyuki; Kinoshita, Fumie; Kuwatsuka, Yachiyo; Ando, Masahiko; et al. (Cancer Medicine, 2026)